← Retour à la une
États-Unis · Plateformes & données · MarketBeat

Vaxcyte, Inc. (NASDAQ:PCVX) Stock Has Average Target Price of $110.50 According to Analysts

Publié par MarketBeat · États-Unis il y a 35 min
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Shares of Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) have received an average recommendation of "Moderate Buy" from the nine brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold reco

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

À lire aussi

Seeking Alpha

Merck KGaA Non-GAAP EPS of €2.32, revenue of €5.63B; raises FY2026 outlook

 The Motley Fool

Procter & Gamble (PG) Has Raised Its Dividend for 70 Straight Years. Here's Why I'd Buy Before 2027.

 Investing.com

UK Q3 GDP rises 0.7% as business services offset construction slump

 TipRanks

GSI Creos Reports Higher Second-Quarter Sales and Profit

 Stocktwits

Nvidia’s Next CEO Could Come From Inside – Or Arm: Here’s Who Traders Are Watching In The Succession Race

 TradingView

Jim Cramer Wants to ‘Throw Up’ Over Nvidia CEO Jensen Huang’s Ouster News, But Elon Musk Says There’s a Better Way